Our Partners
We collaborate with a rich ecosystem of partners to amplify the value our customers gain from both ACTO and our partners’ solutions.
Technology Partners


ACTO’s certified integrations with Veeva and Salesforce enable secure, seamless data and content exchange across platforms—maximizing interoperability and amplifying the value of your technology investment.

As a long-standing Veeva Technology Partner, ACTO’s certified and proven integration with Veeva Vault means our customers can trust the quality of the connection and accelerate their implementation timelines.

ACTO was one of the first members of the Veeva AI Partner program, delivering integrated AI solutions to our customers that leverage Veeva Vault data from PromoMats, MedComms, and CRM.
“Our strategy is to enable our customers and partners to develop AI solutions that work well with any Veeva Vault application. Through Veeva’s AI Partner Program, ACTO can deliver integrated solutions that leverage Veeva Vault data.”
Kristn Peck
Vice President of Alliances
Veeva
ACTOverse
ACTOverse is a digital marketplace available to all ACTO customers that brings together a curated ecosystem of best-in-class partner solutions to extend and enrich the ACTO platform.
ACTOverse simplifies how biopharmaceutical and medical device companies discover, evaluate, and deploy complementary content, data, and services that enhance field training and enablement.
ACTOverse partner solutions are pre-vetted by ACTO and built to work seamlessly with the ACTO platform for turnkey implementation and faster time-to-value.
Resources

ACTO Unveils ACTOverse
Launching with over a dozen trusted partners, ACTOverse brings together content, data, and service solutions that integrate seamlessly with the ACTO platform
Pharma Tech Outlook Cover Story
ACTO recognized as Top Veeva AI Solutions Provider 2025 for its innovation in GenAI.
ACTO Joins the Veeva AI Partner Program
ACTO becomes an early member of the Veeva AI Partner Program to help advance the use of GenAI in life sciences.













